Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes

British Journal of Haematology

Volumn 149, Issue 4, 2010, Pages 587-597

  Xu, Feng ^a   Li, Xiao ^a   Wu, Lingyun ^a   He, Qi ^a   Zhang, Zheng ^a   Chang, Chunkang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

CD34; Flow cytometry; Flow cytometry scoring; Immunotypes; Myelodysplastic syndrome

Indexed keywords

CD34 ANTIGEN; HLA DR15 ANTIGEN; MEMBRANE ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BASIC RESEARCH; BLAST CELL; CELL DIFFERENTIATION; CELL MATURATION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HIGH RISK PATIENT; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; ANTIGENS, NEOPLASM; CHROMOSOME ABERRATIONS; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77951684932     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08146.x     Document Type: Article

References (34)

1. Arjan, A., Theresia, M., August, H., Angelika, M., Vincent, H.J. Gert, J. (2008) Identification of distinct prognostic sub- groups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood, 111, 1067 1077.
2. Auberger, J., Dlaska, M., Auberger, T., Gunsilius, E., Wöll, E. Hilbe, W. (2005) Increased CD133 expression in bone marrow of myelodysplastic syndromes. Leukemia Research, 29, 995 1001. (Pubitemid 40982593)
3. Benesch, M., Deeg, H.J., Wells, D. Loken, M. (2004) Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes. Hematology, 9, 171 177. (Pubitemid 38997056)
4. Biesma, D.H., Van den Tweel, J.G. Verdonck, L.F. (2000) Immunosuppressive therapy for hypoplastic myelodysplastic syndrome. Cancer, 79, 1548 1551.
5. Cherian, S., Moore, J., Bantly, A., Vergilio, J.A., Klein, P., Luger, S. Bagg, A. (2005) Peripheral Blood MDS Score: A New Flow Cytometric Tool for the Diagnosis of Myelodysplastic Syndromes. Cytometry. Part B, Clinical cytometry, 64, 9 17. (Pubitemid 40960407)
6. Corey, S.J., Minden, M.D., Barber, D.L., Kantarjian, H., Wang, J.C. Schimmer, A.D. (2007) Myelodysplastic syndromes: the complexity of stem-cell diseases. Nature Reviews. Cancer, 7, 118 129. (Pubitemid 46164747)
7. Dellaporta, M.G., Malcovati, L., Travaglino, E., Invernizzi, R., Lazzarino, M., Levi, S., Arosio, P. Cazzola, M. (2004) Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Blood, 20, 549 555.
8. Font, P., Subira, D., Mtnez-Chamorro, C., Castańón, S., Arranz, E., Ramiro, S., Gil-Fernandez, J.J., Pascual, J.L., Alonso, A., Perez-Saenz, M.A., Alaez, C., Renedo, M., Blas, C., Escudero, A. Fdez-Ranada, J.M. (2006) Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome. Leukemia Research, 30, 957 963. (Pubitemid 43831185)
9. Gonzalez-Garcia, J.R. Meza-Espinoza, J.P. (2006) Use of the International System for Human Cytogene- tic Nomenclature (ISCN). Blood, 108, 3952 3953.
10. Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079 2088. (Pubitemid 27132124)
11. Horn, P.A., Tesch, H., Staib, P., Kube, D., Diehl, V. Voliotis, D. (1999) Expression of CD133, a novel hematopoietic p recursor antigen, on acute myeloid leukemia cells. Blood, 93, 1435 1437. (Pubitemid 29076163)
12. Kook, H., W, Zeng., Guibin, C., Kirby, M., Young, N.S. Maciejiewski, J.P. (2001) Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Experimental Hematology, 29, 1270 1277. (Pubitemid 33033303)
13. Loken, M.R., Van de Loosdrecht, A.A., Ogata, K., Orfap, A. Wells, D.A. (2008) Flow cytometry in myelodysplastic syndromes: report from a working conference. Leukemia Research, 32, 5 17. (Pubitemid 350100844)
14. Lorand-Metze, I., Ribeiro, E., Lima, C.S., Batista, L.S. Metze, K. (2007) Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders. Leukemia Research, 31, 147 155. (Pubitemid 44854190)
15. Mihara, K., Takihara, Y. Kimura, A. (2007) Genetic and epigenetic alterations in myelodysplastic syndrome. Cytogenetic Genome Research, 118, 297 303. (Pubitemid 350125269)
16. Miraglia, S., Godfrey, W., Yin, A.H., Atkins, K., Warnke, R., Holden, J.T., Bray, R.A., Waller, E.K. Buck, D.W. (1997) A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood, 90, 5013 5021. (Pubitemid 28007218)
17. Nand, S. Godwin, J.E. (2006) Hypoplastic myelodysplastic syndrome. Cancer, 62, 958 964.
18. Ogata, K. (2008) Diagnostic flow cytometry for low-grade myelodysplastic syndromes. Hematological Oncology, 26, 193 198. (Pubitemid 350100844)
19. Ogata, K., Nakamura, K., Yokose, N., Tamura, H., Tachibana, M., Taniguchi, O., Iwakiri, R., Hayashi, T., Sakamaki, H., Murai, Y., Tohyama, K., Tomoyasu, S., Nonaka, Y., Mori, M., Dan, K. Yoshida, Y. (2002) Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood, 100, 3887 3896. (Pubitemid 35396853)
20. Ogata, K., Kishikawa, Y., Satoh, C., Tamura, H., Dan, K. Hayashi, A. (2006) Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood, 108, 1037 1044. (Pubitemid 44154642)
21. Olerp, O. Zetterqueist, H. (1992) HLA-DR typing by PCR-amplification with sequence primers in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens, 39, 225 235.
22. Pirruccello, S.J., Young, K.H. Aoun, P. (2006) Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common. American Journal of Clinical Pathology, 125, 842 894. (Pubitemid 43801539)
23. Satoh, K., Tamura, H., Yamashita, T., Tsuji, T., Dan, K. Ogata, K. (2009) Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes. Leukemia Research, 33, 326 331.
24. Saunthararajah, Y., Nakamura, R., Nam, J.M., Robyn, J., Loberiza, F., Maciejewski, J.P., Simonis, T., Molldrem, J., Young, N.S. Barrett, A.J. (2002) HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood, 100, 1570 1574. (Pubitemid 34925129)
25. Sperling, C., Schwartz, S., Büchner, T., Thiel, E. Ludwig, W.D. (1997) Expression of the stem cell factor receptor C-KIT (CD117) in acute leukemias. Haematologica, 82, 617 621. (Pubitemid 28023263)
26. Stachurski, D., Smith, B.R., Pozdnyakova, O., Anderson, M., Xiao, Z.F., Raza, A., Woda, B.A. Wang, S.A. (2008) Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls. Leukemia Research, 32, 215 224. (Pubitemid 351215540)
27. Stetler-Stevenson, M., Arthur, D.C., Jabbour, N., Xie, X.Y., Molldrem, J., Barrett, A.J., Venzon, D. Rick, M.E. (2001) Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood, 98, 979 987.
28. Tauro, S., Hepburn, M.D., Peddie, C.M., Bowen, D.T. Pippard, M.J. (2002) Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes. Leukemia, 16, 785 790. (Pubitemid 34537549)
29. Tiu, R., Gondek, L., O'Keefe, C. Maciejewski, J.P. (2007) Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes. Leukemia, 21, 1648 1657. (Pubitemid 47086755)
30. Valent, P., Horny, H.P., Bennett, J.M., Fonatsch, C., Germing, U., Greenberg, P., Haferlach, T., Haase, D., Kolb, H.J., Krieger, O., Loken, M., Van de Loosdrecht, A., Ogata, K., Orfao, A., Pfeilstocker, M., Ruter, B., Sperr, W.R., Stauder, R. Wells, D.A. (2007) Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leukemia Research, 31, 727 736. (Pubitemid 46855901)
31. Van de Loosdrecht, A.A., Alhan, C., Christine Béné, M., Matteo, G., Angelika, M., Feuillard, J. Font, P. (2009) Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometric in myelodysplastic syndromes. Haematologica, 94, 1124 1134.
32. Vardiman, J.W., Harris, N.L. Brunning, R.D. (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 100, 2292 2302.
33. Wells, D.A., Benesch, M., Loken, M.R., Vallejo, C., Myerson, D., Leisenring, W.M. Deeg, H.J. (2003) Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood, 102, 394 403. (Pubitemid 36759682)
34. Zang, D.Y., Goodwin, R.G., Loken, M.R., Bryant, E. Deeg, H.J. (2001) Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. Blood, 98, 3058 3065.